Black Diamond Therapeutics (BDTX) Other Non-Current Assets (2019 - 2026)
Black Diamond Therapeutics (BDTX) posted Other Non-Current Assets of $29000.0 for Q1 2026, down 96.5% on a QoQ basis from $829000.0 in Q4 2025, and down 96.47% year-over-year from $821000.0 in Q1 2025.
Black Diamond Therapeutics (BDTX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Black Diamond Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $29000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 96.47% year-over-year to $29000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29000.0 (down 96.47% YoY) and the FY2025 annual result came in at $829000.0, up 1.22% from the prior year.
- Other Non-Current Assets was $29000.0 for Q1 2026 at Black Diamond Therapeutics, down from $829000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.2 million in Q2 2023 and bottomed at $29000.0 in Q1 2026.
- A 5-year average of $863000.0 and a median of $824000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets advanced 5.14% — and 2026, when it tumbled 96.47%.
- Black Diamond Therapeutics' Other Non-Current Assets stood at $1.2 million in 2022, then slipped by 29.54% to $823000.0 in 2023, then retreated by 0.49% to $819000.0 in 2024, then climbed by 1.22% to $829000.0 in 2025, then plunged by 96.5% to $29000.0 in 2026.
- Business Quant data shows BDTX's Other Non-Current Assets at $29000.0 in Q1 2026, $829000.0 in Q4 2025, and $117000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | 29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | 829,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 824,000.00 |
| Mar 31, 2025 | 821,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Sep 30, 2024 | 826,000.00 |
| Jun 30, 2024 | 822,000.00 |
| Mar 31, 2024 | 819,000.00 |
| Dec 31, 2023 | 823,000.00 |
| Sep 30, 2023 | 819,000.00 |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.22 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 1.22 Mn |